WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-04-081,028$14.82
$15.23kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-04-082,708$14.82
$40.13kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-03-263,171$17.05
$54.07kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-03-261,095$17.05
$18.67kSell
Elizabeth A. GarofaloDirector2025-03-054,919$18.23
$89.67kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-02-24475$19.96
$9.48kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-02-24773$19.96
$15.43kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2024-11-194,073$16.81
$68.47kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2024-11-1910,259$16.81
$172.45kSell
Brendan TeehanEVP COO HEAD OF COMMERCIAL2024-11-1910,329$16.81
$173.63kSell

1 of 2

ACAD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP25.71%42,877,916$616.58MInstitution
Baker Bros Advisors LP23.65%39,452,627$567.33MInsider
Baker Brothers Life Sciences LP8.53%14,229,612$204.62MInsider
Vanguard Group Inc8.36%13,947,640$200.57MInstitution
Blackrock Inc7.63%12,729,859$183.06MInstitution
Rtw Investments LP5.22%8,705,501$125.19MInstitution
Morgan Stanley4.38%7,297,049$104.93MInstitution
State Street Corp2.71%4,521,385$65.02MInstitution
D E Shaw Co Inc1.94%3,241,406$46.61MInstitution
Oxford Bioscience Partners IV LP1.89%3,160,238$45.44MInsider

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD71.61%28.39%Net SellingNet Selling
IMVT44.70%55.30%Net BuyingNet Selling
VCYT65.76%34.24%Net SellingNet Selling
IBRX9.68%8.96%Net BuyingNet Selling
MTSR0.00%67.20%Net BuyingNet Buying
View Top Biotech Stocks

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 97.65% institutional shareholders, 38.71% Acadia Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.45M shares representing 23.65% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $566.15M.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.